Subscribe

DOI:

How to become an Andreas Grüntzig in the 21st century

How to become an Andreas Grüntzig in the 21 century

Bernhard Meier

The contributions of Andreas Grüntzig to modern medicine are huge, though it may be argued that serendipity accounted for a significant part of his success. He came to Zürich to be a disciple of Robert Hegglin, an internist. Hegglin died shortly after Grüntzig’s arrival, obliging him to find a substitute tutor in the person of Alfred Bollinger, an angiologist, whose diagnostic skills he quickly acquired.

As a step still further, Grüntzig then became intrigued by the fact that unblocking arteries appeared to be conceptually simple. Charles Dotter had already shown how to dilate peripheral arteries with incremental catheters and Dotter must have given balloons a thought. However, it was Grüntzig who happened to run into a plastics expert who knew how to make a functioning dilatation balloon. Grüntzig appeared to be in danger of jeopardising the sovereignty of cardiac surgery and yet it just so happened that Åke Senning was the local chief surgeon. Senning already enjoyed considerable personal fame and was happy to share the limelight with this young cardiologist in the ascendant who was threatening to eclipse him. Lastly, Grüntzig’s first case just happened to be as good as they come – almost forty years on, his first patient has never needed bypass surgery!

While such a constellation was unlikely at the time, it would be unthinkable today. Critics would stop a Grüntzig of our times, raising ethical and regulatory red flags. His story could not be reconciled with today’s evidence-based medicine and research rigour. Yet, creative minds continue to exist and, to help them make their dreams come true, specialists have emerged alongside ever more restrictive regulations. Medical breakthroughs are still possible and young physicians must continue to strive for them. They can no longer be accomplished by a single person but the required algorithms and the money still exist. The secret is to think out of the box but not act out of the box. Casey Kasem knew it all along when he proclaimed, “Keep reaching for the stars but keep your feet on the ground”.

Bernhard Meier, MD

Professor of Cardiology, University Hospital of Bern, Bern, Switzerland

[email protected]

NEWS

EAPCI General Assembly Thursday 18 May, 10:30-12:00, Room 343! Join us and and learn about the latest developments of our Association. EAPCI Voting members will be invited to vote on a proposal for a new mission for the Association. Be there! We look forward to seeing you...

Don’t miss the free EAPCI webinar on 23 June, from 18:00 to 19:00 CET.

Join Dr R. Byrne, Professors M. Roffi and A. Baumbach for a “Focus on bleeding management strategy in patients under oral anticoagulation after PCI – from randomized clinical trials to the individual patient”.

Register online: www.escardio.org/EAPCI - Education section

Keep up to date about all the exciting upcoming European Society of Cardiology (ESC) webinars at www.escardio.org - Education section

Volume 13 Number 1
May 15, 2017
Volume 13 Number 1
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00022 Sep 15, 2025
An ongoing quest to discern the optimal antithrombotic therapy after TAVI
Hayashida K and Iwata J
free

Translational research

10.4244/EIJ-D-24-01000 Sep 15, 2025
DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
Meier D et al
open access

Research Correspondence

10.4244/EIJ-D-25-00255 Sep 15, 2025
Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves
Tarantini G et al

Original Research

10.4244/EIJ-D-24-01066 Sep 15, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulation
Overduin D et al

Editorial

10.4244/EIJ-E-25-00038 Sep 15, 2025
Evolving cutoff values for optimising left main stenting with intravascular imaging
de la Torre Hernandez J
free

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free

Flashlight

10.4244/EIJ-D-25-00121 Sep 15, 2025
Calcium mapping by 3DStent technology
Amabile N and Benamer H
Trending articles
76.3

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
46.7

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
28.25

Clinical research

10.4244/EIJ-D-19-01006 Aug 7, 2020
Coronary collaterals and myocardial viability in patients with chronic total occlusions
Schumacher S et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
Can you provide a summary of the key findings in this article?
Can you extract and explain the primary hypothesis or research question addressed in this article?
What are the potential clinical applications or implications of the results presented in this paper?
How does this research contribute to our current understanding of cardiovascular disease management?
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved